Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

Patients with schizophrenia have a lot of life-changing consequences when they are being treated properly, and these are only amplified when the patient goes untreated, explained Megan Ehret, PharmD, ...

CT-155 is a smartphone app that integrates psychosocial interventions delivered using an adaptive goal-setting technique. A ...

A Case Western Reserve University study suggests a major shift in schizophrenia treatment -- one that focuses on helping ...

More than 92% of schizophrenia patients taking Olanzapine LAI in the Phase 3 SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication 1.

Panelists discuss how prescription digital therapeutics are currently used in clinical practice, noting that while none are ...

A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.

Pea-sized brains grown in a lab have for the first time revealed the unique way neurons might misfire due to schizophrenia and bipolar disorder, psychiatric ailments that affect millions of people ...

Detailed price information for Alto Neuroscience Inc (ANRO-N) from The Globe and Mail including charting and trades.

Schizophrenia is a severe and debilitating psychiatric disorder characterized by hallucinations, disorganized speech and ...